The role of EGFR family in preneoplasia and lung cancer; Perspectives for targeted therapies and selection of patients

Fred R.Hirsch

首页> 外文期刊>European Journal of Cancer Supplements >The role of EGFR family in preneoplasia and lung cancer; Perspectives for targeted therapies and selection of patients

【24h】

The role of EGFR family in preneoplasia and lung cancer; Perspectives for targeted therapies and selection of patients

机译：EGFR家族在肿瘤形成前和肺癌中的作用;靶向疗法和患者选择的前景

获取原文

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《European Journal of Cancer Supplements》 |2006年第6期|共2页
作者
Fred R.Hirsch;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种
中图分类肿瘤学;
关键词

相似文献

外文文献
中文文献
专利

1. Epidermal growth factor family of receptors in preneoplasia and lung cancer: perspectives for targeted therapies. [J] . Hirsch FR, Scagliotti GV, Langer CJ, Lung cancer: Journal of the International Association for the Study of Lung Cancer . 2003,第Suppla1期

机译：表皮生长因子受体家族在前肿瘤和肺癌中的应用：靶向治疗的观点。
2. Anti-EGFR targeted therapies combined with chemoradiotherapy in patients with locally advanced non-small cell lung cancer [Association des thérapeutiques ciblées anti-EGFR avec la radio-chimiothérapie chez les patients présentant un cancer bronchique non à petites cellules localement avancé] [J] . ArpinD., PourelN. Oncologie. . 2012,第5期

机译：抗EGFR靶向疗法联合放化疗治疗局部晚期非小细胞肺癌患者[抗EGFR靶向疗法与放射化疗联合治疗局部晚期非小细胞肺癌患者]
3. Targeted therapies: Importance of patient selection for EGFR TKIs in lung cancer. [J] . Lopez Chavez A, Giaccone G Nature reviews. Clinical oncology . 2010,第7期

机译：靶向疗法：选择肺癌患者中EGFR TKIs的重要性。
4. Association between tumor heterogeneity and progression-free survival in non-small cell lung cancer patients with EGFR mutations undergoing tyrosine kinase inhibitors therapy [C] . Jiangdian Song, Di Dong, Yanqi Huang, Annual International Conference of the IEEE Engineering in Medicine and Biology Society . 2016

机译：接受酪氨酸激酶抑制剂治疗的EGFR突变非小细胞肺癌患者肿瘤异质性与无进展生存的关系
5. Application of Quantitative Metrics for EGFR-Targeted Non-Small Cell Lung Cancer Therapy Using [11C]Erlotinib PET. [D] . Petrulli, Joseph Ryan. 2017

机译：定量指标在EGFR靶向非小细胞肺癌治疗中的应用[11C]厄洛替尼PET。
6. Postoperative survival of EGFR-TKI-targeted therapy in non-small cell lung cancer patients with EGFR 19 or 21 mutations: a retrospective study [O] . Wenjing Yang, Yibo Gao, Xuelian Li, 2017

机译：回顾性研究：EGFR-TKI靶向治疗在EGFR 19或21突变的非小细胞肺癌患者中的术后生存率
7. The role of EGFR family in preneoplasia and lung cancer; Perspectives for targeted therapies and selection of patients [O] . Hirsch Fred R. 2006

机译：EGFR家族在肿瘤形成前和肺癌中的作用；靶向疗法和患者选择的前景
8. Deficient BIM Expression as a Mechanism of Intrinsic and Acquired Resistance to Targeted Therapies in EGFR Mutant and ALK Positive Lung Cancers. [R] . Sequist, L., Engelman, J. 2016

机译：缺乏BIm表达作为EGFR突变体和aLK阳性肺癌中靶向治疗的内在和获得性抗性的机制。

The role of EGFR family in preneoplasia and lung cancer; Perspectives for targeted therapies and selection of patients

著录项

相似文献

相关主题

期刊订阅